Research Article
The Association of Serum AIM2 Level with the Prediction and Short-Term Prognosis of Coronary Artery Disease
Table 1
Baseline characteristics of the study population.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as (%), mean and standard deviation, or median (25th, 75th). CAD: coronary artery disease; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; DM: diabetes mellitus; Af: atrial fibrillation; LA: left atrium; LV: left ventricle; LVEF: left ventricular ejection fraction; WBC: white blood cell; RBC: red blood cell; Hb: hemoglobin; Plt: platelet; Hct: hematocrit; TSB: total serum bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; Scr: serum creatinine; UA: uric acid; TG: triglyceride; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Apoa: apolipoprotein (a); eGFR-MDRD: estimated glomerular filtration rate based on MDRD equation; ADP: adenosine diphosphate; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker. |